Department of Health (DOH): Vital statistics, 2007. 2008, Taiwan: Department of Health, the Executive Yuen
Google Scholar
Yuen MF, Tanaka Y, Fong DY, Fung J, Wong DK, Yuen JC, But DY, Chan AO, Wong BC, Mizokami M, Lai CL: Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B. J Hepatol. 2009, 50: 80-88. 10.1016/j.jhep.2008.07.023.
Article
PubMed
Google Scholar
Liaw YF, Chu CM: Hepatitis B virus infection. Lancet. 2009, 373: 582-592. 10.1016/S0140-6736(09)60207-5.
Article
CAS
PubMed
Google Scholar
Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, Liang DC, Shau WY, Chen DS: Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med. 1997, 336: 1855-1859. 10.1056/NEJM199706263362602.
Article
CAS
PubMed
Google Scholar
Chen HL, Chang MH, Ni YH, Hsu HY, Lee PI, Lee CY, Chen DS: Seroepidemiology of hepatitis B virus infection in children: Ten years of mass vaccination in Taiwan. JAMA. 1996, 276: 906-908. 10.1001/jama.1996.03540110060032.
Article
CAS
PubMed
Google Scholar
Chang MH, You SL, Chen CJ, Liu CJ, Lee CM, Lin SM, Chu HC, Wu TC, Yang SS, Kuo HS, Chen DS: Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. J Natl Cancer Inst. 2009, 101: 1348-1355. 10.1093/jnci/djp288.
Article
CAS
PubMed
Google Scholar
Chen CJ, Yu MW, Liaw YF: Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol. 1997, 12: 294-308. 10.1111/j.1440-1746.1997.tb00513.x.
Article
Google Scholar
Chien RN, Sheen IS, Liaw YF: Low prevalences of HBV and HCV infection in patients with primary biliary cirrhosis in Taiwan: a case control study. J Gastroenterol Hepatol. 1993, 8: 574-576. 10.1111/j.1440-1746.1993.tb01655.x.
Article
CAS
PubMed
Google Scholar
Hoshuyama T, Pan G, Tanaka C, Feng Y, Yu L, Liu T, Liu L, Hanaoka T, Takahashi K: Mortality of iron-steel workers in Anshan, China: a retrospective cohort study. Int J Occup Environ Health. 2006, 12: 193-202.
Article
CAS
PubMed
Google Scholar
Huang X: Iron overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal. Mutat Res. 2003, 533: 153-171. 10.1016/j.mrfmmm.2003.08.023.
Article
CAS
PubMed
Google Scholar
Sorrentino P, D'Angelo S, Ferbo U, Micheli P, Bracigliano A, Vecchione R: Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis. J Hepatol. 2009, 50: 351-357. 10.1016/j.jhep.2008.09.011.
Article
CAS
PubMed
Google Scholar
Wu HC, Wang Q, Yang HI, Ahsan H, Tsai WY, Wang LY, Chen SY, Chen CJ, Santella RM: Aflatoxin B1 exposure, hepatitis B virus infection, and hepatocellular carcinoma in Taiwan. Cancer Epidemiol Biomarkers Prev. 2009, 18: 846-853. 10.1158/1055-9965.EPI-08-0697.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yu MW, Hsieh HH, Pan WH, Yang CS, CHen CJ: Vegetable consumption, serum retinol level, and risk of hepatocellular carcinoma. Cancer Res. 1995, 55: 1301-1305.
CAS
PubMed
Google Scholar
Dietz NA, Sherman R, Mackinnon J, Fleming L, Arheart KL, Wohler B, Lee DJ: Toward the identification of communities with increased tobacco-associated cancer burden: application of spatial modeling techniques. J Carcinog. 2011, 10: 22-10.4103/1477-3163.85184.
Article
PubMed
PubMed Central
Google Scholar
Mohebbi M, Wolfe R, Jolley D, Forbes AB, Mahmoodi M, Burton RC: The spatial distribution of esophageal and gastric cancer in Caspian region of Iran: an ecological analysis of diet and socio-economic influences. Int J Health Geogr. 2011, 10: 13-10.1186/1476-072X-10-13.
Article
PubMed
PubMed Central
Google Scholar
Chen CJ, Kuo TL, Wu MM: Arsenic and cancers. Lancet. 1988, 1: 414-415.
Article
CAS
PubMed
Google Scholar
Esteve J, Benhamou E, Raymond L: Statistical methods in cancer research. Volume IV. Descriptive epidemiology. 1994, Lyon: (IARC Scientific Publications No. 128), International Agency for Research on cancer, 52-
Google Scholar
Lee CL, Ko YC, Choong CS: Survival rate for liver cancer in Taiwan. Zhonghua Yi Xue Za Zhi. 2000, 63: 16-20.
CAS
PubMed
Google Scholar
Chen SY, Liu TY, Chen MJ, Lin JT, Sheu JC, Chen CJ: Seroprevalences of hepatitis B and C viruses and Helicobacter pylori infection in a small, isolated population at high risk of gastric and liver cancer. Int J Cancer. 1997, 71: 776-779. 10.1002/(SICI)1097-0215(19970529)71:5<776::AID-IJC14>3.0.CO;2-6.
Article
CAS
PubMed
Google Scholar
Chang CC, Yu MW, Lu CF, Yang CS, Chen CJ: A nested case–control study on association between hepatitis C virus antibodies and primary liver cancer in a cohort of 9,775 men in Taiwan. J Med Virol. 1994, 43: 276-280. 10.1002/jmv.1890430315.
Article
CAS
PubMed
Google Scholar
Chen DS, Kuo GC, Sung JL, Lai MY, Sheu JC, Chen PJ, Yang PM, Hsu HM, Chang MH, Chen CJ: Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. J Infect Dis. 1990, 162: 817-822. 10.1093/infdis/162.4.817.
Article
CAS
PubMed
Google Scholar
Lu SN, Lin TM, Chen CJ, Chen JS, Liaw YF, Chang WY, Hsu ST: A case–control study of primary hepatocellular carcinoma in Taiwan. Cancer. 1988, 62: 2051-2055. 10.1002/1097-0142(19881101)62:9<2051::AID-CNCR2820620930>3.0.CO;2-1.
Article
CAS
PubMed
Google Scholar
Sun CA, Farzadegan H, You SL, Lu SN, Wu MH, Wolfe L, Hardy W, Huang GT, Yang PM, Lee H, Chen CJ: Mutual confounding and interactive effects between hepatitis C and hepatitis B viral infections in hepatocellular carcinogenesis: a population-based case–control study in Taiwan. Cancer Epidemiol Biomarkers Prev. 1996, 5: 173-178.
CAS
PubMed
Google Scholar
Yu MW, You SL, Chang AS, Lu SN, Liaw YF, Chen CJ: Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan. Cancer Res. 1991, 51: 5621-5625.
CAS
PubMed
Google Scholar
Chen CJ, Lu SN, You SL, Wu MH, Wang LY, Lee LT, Huang GT, Yang PM, Lee HS: Community-based hepatocellular carcinoma screening in seven townships in Taiwan. J Formos Med Assoc. 1995, 94: 94-102.
Google Scholar
Lu JN, Chen CJ: Prevalence of hepatitis B surface antigen carrier status among residents in the endemic area of chronic arsenicism in Taiwan. Anticancer Res. 1991, 11: 229-233.
CAS
PubMed
Google Scholar
Wang LY, Cheng YW, Chou SJ, Hsieh LL, Chen CJ: Secular trend and geographical variation in hepatitis A infection and hepatitis B carrier rate among adolescents in Taiwan: an island-wide survey. J Med Virol. 1993, 39: 1-5. 10.1002/jmv.1890390102.
Article
CAS
PubMed
Google Scholar
Chen CH, Yang PM, Huang GT, Lee HS, Sung JL, Sheu JC: Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants. J Formos Med Assoc. 2007, 106: 148-155. 10.1016/S0929-6646(09)60231-X.
Article
PubMed
Google Scholar
Turlin B, Juguet F, Moirand R, Le Quilleuc D, Loréal O, Campion JP, Launois B, Ramée MP, Brissot P, Deugnier Y: Increased liver iron stores in patients with hepatocellular carcinoma developed on a noncirrhotic liver. Hepatology. 1995, 22: 446-450.
CAS
PubMed
Google Scholar
Kowdley KV: Iron, hemochromatosis, and hepatocellular carcinoma. Gastroenterology. 2004, 127: S79-S86. 10.1016/j.gastro.2004.09.019.
Article
CAS
PubMed
Google Scholar
Di Bisceglie AM: Hepatitis C and hepatocellular carcinoma. Hepatology. 1997, 26: S34-S38. 10.1002/hep.510260706.
Article
Google Scholar
Kato J, Kobune M, Nakamura T, Kuroiwa G, Takada K, Takimoto R, Sato Y, Fujikawa K, Takahashi M, Takayama T, Ikeda T, Niitsu Y: Normalization of elevated hepatic 8-hydroxy-20-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet. Cancer Res. 2001, 61: 8697-8702.
CAS
PubMed
Google Scholar
Yano M, Hayashi H, Yoshioka K, Kohgo Y, Saito H, Niitsu Y, Kato J, Iino S, Yotsuyanagi H, Kobayashi Y, Kawamura K, Kakumu S, Kaito M, Ikoma J, Wakusawa S, Okanoue T, Sumida Y, Kimura F, Kajiwara E, Sata M, Ogata K: A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: a multicenter, prospective, randomized, controlled trial in Japan. J Gastroenterol. 2004, 39: 570-574.
Article
CAS
PubMed
Google Scholar
Soe K, Hishikawa Y, Fukuzawa Y, Win N, Yin KS, Win KM, Myint AA, Koji T: Possible correlation between iron deposition and enhanced proliferating activity in hepatitis C virus-positive hepatocellular carcinoma in Myanmar (Burma). J Gastroenterol. 2007, 42: 225-235. 10.1007/s00535-006-1993-9.
Article
CAS
PubMed
Google Scholar
An S, Soe K, Akamatsu M, Hishikawa Y, Koji T: Accelerated proliferation of hepatocytes in rats with iron overload after partial hepatectomy. Histochem Cell Biol. 2012, 138: 773-786. 10.1007/s00418-012-0994-4.
Article
CAS
PubMed
Google Scholar
Liu CW, Lin WS, Shang C, Liu SH: The effect of clay dehydration on land subsidence in the Yun-Lin coastal area, Taiwan. Environ Geol. 2001, 40: 518-527. 10.1007/s002540000193.
Article
Google Scholar
World Health Organization (WHO): Iron in Drinking-water. Background document for development of WHO Guidelines for Drinking-water Quality. 1996, Geneva: World Health Organization
Google Scholar
Papanikolaou G, Pantopoulos K: Iron metabolism and toxicity. Toxicol Appl Pharmacol. 2005, 202: 199-211. 10.1016/j.taap.2004.06.021.
Article
CAS
PubMed
Google Scholar
Toyokuni S: Role of iron in carcinogenesis: cancer as a ferrotoxic disease. Cancer Sci. 2009, 100: 9-16. 10.1111/j.1349-7006.2008.01001.x.
Article
CAS
PubMed
Google Scholar
Kew MC: Hepatic iron overload and hepatocellular carcinoma. Cancer Lett. 2009, 286: 38-43. 10.1016/j.canlet.2008.11.001.
Article
CAS
PubMed
Google Scholar
Hori A, Mizoue T, Kasai H, Kawai K, Matsushita Y, Nanri A, Sato M, Ohta M: Body iron store as a predictor of oxidative DNA damage in healthy men and women. Cancer Sci. 2010, 101: 517-522. 10.1111/j.1349-7006.2009.01394.x.
Article
CAS
PubMed
Google Scholar
Stevens RG, Beasley RP, Blumberg BS: Iron-binding proteins and risk of cancer in Taiwan. J Natl Cancer Inst. 1986, 76: 605-610.
CAS
PubMed
Google Scholar
Finch CA, Huebers H: Perspectives in iron metabolism. N Engl J Med. 1982, 306: 1520-1528. 10.1056/NEJM198206243062504.
Article
CAS
PubMed
Google Scholar
Rocha LA, Barreto DV, Barreto FC, Dias CB, Moysés R, Silva MR, Moura LA, Draibe SA, Jorgetti V, Carvalho AB, Canziani ME: Serum ferritin level remains a reliable marker of bone marrow iron stores evaluated by histomorphometry in hemodialysis patients. Clin J Am Soc Nephrol. 2009, 4: 105-109. 10.2215/CJN.01630408.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rushton DH, Barth JH: What is the evidence for gender differences in ferritin and haemoglobin?. Crit Rev Oncol Hematol. 2010, 73: 1-9. 10.1016/j.critrevonc.2009.03.010.
Article
PubMed
Google Scholar
Røsvik AS, Ulvik RJ, Wentzel-Larsen T, Hervig T: The effect of blood donation frequency on iron status. Transfus Apher Sci. 2009, 41: 165-169. 10.1016/j.transci.2009.09.017.
Article
PubMed
Google Scholar
Whitfield JB, Treloar S, Zhu G, Powell LW, Martin NG: Relative importance of female-specific and non-female-specific effects on variation in iron stores between women. Br J Haematol. 2003, 120: 860-866. 10.1046/j.1365-2141.2003.04224.x.
Article
PubMed
Google Scholar
Leggett BA, Brown NN, Bryant SJ, Duplock L, Powell LW, Halliday JW: Factors affecting the concentrations of ferritin in serum in a healthy Australian population. Clin Chem. 1990, 36: 1350-1355.
CAS
PubMed
Google Scholar